Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)
about
Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanomaLong-term survival as a treatment benchmark in melanoma: latest results and clinical implicationsLong-term follow-up for melanoma patients: is there any evidence of a benefit?State of melanoma: an historic overview of a field in transition.Radical irradiation of extracranial oligometastases.A 20-year experience of hepatic resection for melanoma: is there an expanding role?Long-term survival in advanced melanoma patients using repeated therapies: successive immunomodulation improving the odds?Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma.Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis.Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment.High-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients with Melanoma Brain Metastases.Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.Liver resection and ablation for metastatic melanoma: A single center experienceMetastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma.Impact of targeted neoadjuvant therapies in the treatment of solid organ tumours.Metastatic melanoma to the upper aerodigestive tract: a systematic review of the literature.Thyroid metastasectomy.Isolated limb perfusion for in-transit melanoma metastases: melphalan or TNF-melphalan perfusion?Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanoma.Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indication.18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanomaSentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta-analysis.Combinatorial immunotherapy for melanoma.Metastatic Melanoma to the Bladder: Case Report and Review of the Literature.The Role of Surgery for Melanoma in an Era of Effective Systemic Therapy.Association of Surgical Treatment, Systemic Therapy, and Survival in Patients With Abdominal Visceral Melanoma Metastases, 1965-2014: Relevance of Surgical Cure in the Era of Modern Systemic Therapy.Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma.Melanoma: the role of surgery in the era of new therapies.The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.Complete metastasectomy after high-dose interleukin-2 (HD IL-2) therapy for melanoma.Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanoma.Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.The changing landscape of dermatology practice: melanoma and pump-probe laser microscopy.Stage IV melanoma: completely resectable patients are scarce.Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)Surgical resection of metastatic melanoma in the era of immunotherapy and targeted therapy
P2860
Q24187945-3DD208B7-FD24-4523-89E3-3408EF82BBEEQ26775546-35D444E8-F1FD-4FD6-B786-B87A5D9AAAC0Q27007043-32E12D3B-8AC1-475B-BF06-154CCBD61B9FQ33693906-91F118DB-083E-4B09-A45B-460B4D5E66BBQ34124296-E3FB472E-6BB5-4908-9AE8-0D6499293719Q34150440-02F0D673-A66B-4FAD-963C-8E2097E118DCQ34477227-CB9D892F-ABBD-43A7-A9D2-655293E690A2Q34534663-A77CA54F-8CDF-46B9-B2CB-EB1B5A9D2755Q35231246-99699FA2-0E24-4929-BF4F-591681065C93Q35821826-90F2A0DB-FE6E-411D-806D-7C434400B8C0Q36883292-6CAAA248-FF2A-4BC7-831D-5514BF7BF7D4Q37417271-100CC818-BBDD-4ADF-AD60-C6B643A841AAQ37518270-727AB0A3-FEB6-4BF5-88BE-5A4C0A06AE10Q37528784-32A4AEBA-F839-4701-81EB-2A0D6ABBB8BDQ38061098-B917486F-4E96-4938-9015-6C9E274834C6Q38151617-A5CB0E13-F851-42E7-A2F1-309CAD7277FEQ38152342-C77A2BAF-D278-4B59-B449-AD3D5A83CE3DQ38176854-131D7D13-A59C-45BD-BD42-35B418F2985BQ38312053-E2E72AA9-6FD2-4688-920B-AED5CF4E2823Q38529540-CB911BC6-29AB-409D-847B-E6DCA42A0CE2Q38663172-E5DE0065-4CA6-4934-BC1D-D2960CB1FFE1Q38945950-B431C6B5-3835-437A-8BE4-F4AB0B80EA30Q39005199-EC51FC18-1488-4583-B0CD-7E185A2F335DQ39084868-49957E5E-9074-42BD-AA79-AECEE8298062Q39157489-728AC97E-1B67-4846-B402-C3FF5006F6ACQ39224672-3EED277F-7B5D-4A7A-8213-400FCDB0BC71Q40524925-2AFC6B18-8CAE-4AD2-858A-B81BBA2CA86BQ42744580-25F88B9B-9BDE-45BD-9618-1461BDA187CCQ43556611-D9C4B535-F0B6-4750-96F2-A44893F71FDAQ43705084-FEE4E315-5165-4F90-BF18-66C4329E22E1Q45893054-B369436B-D6A4-4194-A996-B4FD1BA388EDQ46617410-486F3F51-40A0-4640-873A-BFAEC4B4BCA7Q46847441-B68E6D8B-8B73-4336-89CB-FED48D6C03A2Q47692272-4BBC9459-2683-45CA-8AD7-ACEC323450CAQ50873280-BF68C10A-2B8C-4C49-8DF5-935EBE692E87Q56523838-A726E29D-BCA3-4CC2-B55B-E5139DF554DEQ56894275-7294D6DA-A5FC-4B5B-888A-9572D6810F34
P2860
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Metastasectomy for distant met ...... Lymphadenectomy Trial (MSLT-I)
@ast
Metastasectomy for distant met ...... Lymphadenectomy Trial (MSLT-I)
@en
Metastasectomy for distant met ...... elective Lymphadenectomy Trial
@nl
type
label
Metastasectomy for distant met ...... Lymphadenectomy Trial (MSLT-I)
@ast
Metastasectomy for distant met ...... Lymphadenectomy Trial (MSLT-I)
@en
Metastasectomy for distant met ...... elective Lymphadenectomy Trial
@nl
prefLabel
Metastasectomy for distant met ...... Lymphadenectomy Trial (MSLT-I)
@ast
Metastasectomy for distant met ...... Lymphadenectomy Trial (MSLT-I)
@en
Metastasectomy for distant met ...... elective Lymphadenectomy Trial
@nl
P2093
P2860
P1476
Metastasectomy for distant met ...... Lymphadenectomy Trial (MSLT-I)
@en
P2093
Alistair J Cochran
B Mark Smithers
Brendon J Coventry
Constantine P Karakousis
Daniel F Roses
Donald L Morton
Douglas S Reintgen
Harald J Hoekstra
J Harrison Howard
John F Thompson
P2860
P2888
P304
P356
10.1245/S10434-012-2398-Z
P577
2012-05-31T00:00:00Z
P6179
1036889506